Liver fibro-inflammation in psoriatic arthritis with MASLD improved by anti-IL-17 treatment: a clinical case

A 37-year-old woman with psoriatic arthritis and undiagnosed liver disease showed significant reversal of liver fibro-inflammation after 6 months of IL-17A inhibitor (secukinumab) treatment. Quantitative mpMRI and blood tests confirmed improved liver health, suggesting biologic disease-modifying antirheumatic drugs  may benefit coexisting metabolic liver disease and psoriatic disease.